Replies to post #236431 on Biotech Values

[DewDiligence]

IKT -50% on FDA clinical hold of IND:

https://www.prnewswire.com/news-releases/inhibikase-therapeutics-announces-fda-clinical-hold-on-ikt-148009-programs-301669801.html

The stock is now down 95% from its 2020 IPO.